Navigation Links
Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics
Date:6/19/2013

New York, New York (PRWEB) June 19, 2013

As Januvia lawsuit claims involving pancreatitis and pancreatic cancer continue to mount in courts throughout the U.S., Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) recently held a meeting to discuss the safety of Januvia and other diabetes drugs known as incretin mimetics. According to a June 12th report from Bloomberg.com, the FDA may seek additional data from the makers of Januvia and similar drugs, following a recent study that indicated the medications could increase risks for pancreatic cancer. One of the options being considered by the agency is a large clinical trial designed to show patterns of adverse events. *

“In light of the possible link between Januvia and pancreatic cancer, we certainly hope that the FDA will order more studies of these drugs,” says Bernstein Liebhard LLP, nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Januvia lawsuit evaluations to patients who took the medication and were diagnosed with pancreatic cancer or pancreatitis.

Januvia Lawsuits
Incretin mimetics like Januvia help regulate blood sugar by stimulating insulin production by the pancreas. In 2009, information was added to the drug’s label regarding a potential risk for Januvia pancreatitis, after the FDA became aware of 88 post-marketing cases of acute pancreatitis that occurred in patients taking the drug.** In 2011, a study published in the journal Gastroenterology found that use of Januvia appeared to increase the risk of pancreatitis by as much as six-fold. The same study found a possible link between Januvia and pancreatic cancer.***

The FDA’s recent meeting was prompted by data from an unpublished study that drugs like Januvia could cause precancerous c
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DrugRisk Announces Addition of Januvia Cancer Resource Center
2. Pancreatic Cancer Correlation to Type 2 Diabetes Drugs Januvia and Byetta, New Studies Find Possible Connection
3. DrugRisk Adds New Pancreatic Cancer Warning for Diabetes Drug Januvia
4. Januvia Lawsuits Consultations Now Offered by the Berman Law Group, Januvia Lawyers and Compensation Experts
5. Januvia Lawsuit News: Rottenstein Law Group LLP Comments on Doctor’s Doubts About Januvia
6. Rottenstein Law Group LLP Comments on Drugmakers’ Cooperation With Safety Review of Byetta, Januvia, Victoza
7. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
8. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
9. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
10. New Lawsuit Alleges Teen Molestation by Ex-Deputy
11. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Celebrity hairstylist and Beauty Gives Back Art ... Behind the Fashion” on Thursday, Oct. 1, at the La Valencia Hotel. The presentation, ... the collaboration between fashion and professional hair, makeup and nail design. , The ...
(Date:9/1/2015)... ... September 01, 2015 , ... Pharmaceutical ... different malignancies. Some options for cancer treatment are available belonging to various ... approach is necessary for effective treatment. Several molecules have been discovered out ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Vending Machine,” is still strongly maintaining her firm’s success in the hair care ... In her upcoming city-to-city tour, Ellis will be providing “Look and learn” live ...
(Date:9/1/2015)... ... September 01, 2015 , ... PetPace, the provider of an ... and activity, today announced its integration with leading veterinary Practice Management Software vendor ... hospital Practice Management Software packages in the US. Practice Management Software helps veterinarians ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Zecurion, a leading ... , its groundbreaking new version of endpoint DLP developed specifically for Mac OS. , ... which more than 100 IT and information security professionals had participated. The beta test ...
Breaking Medicine News(10 mins):Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Zecurion Announces Endpoint Security for Mac 2
... 2009 The first results of the first European survey ... at the 6th congress of the European Federation of Chapters ... , Previous surveys have looked at the overall management of ... study to look in detail at Breakthrough Cancer Pain (BTCP) ...
... ... relationship to offer comprehensive staffing, scheduling, and credentialing software to nurse staffing ... no additional charge. , ... Nashville, TN (Vocus) September 11, 2009 -- BlueSky Synergy, LLC (BlueSky) and People ...
... ... Yum-Yum D3 Gummies, Yum-Yum GOS Syrup (prebiotic fiber syrup), and Yum-Yum Zymes at the ... and Exhibition Center in Boston, MA, September 24-26, 2009. , ... Los Angeles, CA (PRWEB) September 11, 2009 ...
... ... dental group practice in central North Carolina, today announced the addition of Dr. Brian Cahill ... ... pleased to announce that Dr. Brian Cahill has joined their cosmetic and family dental practice. ...
... , , NEW YORK, Sept. 10 ... The Mount Sinai Medical Center describe the Community Diabetes and ... program which was designed specifically for people from the vulnerable Latino ... Twenty-five patients from The Mount Sinai Medical Center were randomly selected ...
... speed immunity, experts say , THURSDAY, Sept. 10 (HealthDay ... vaccine conducted in Australia and Britain show that a ... virus within about 10 days. , That,s a potentially ... would be needed to provide full immunity to the ...
Cached Medicine News:Health News:First results from major European patient survey show devastating impact of living with breakthrough cancer pain 2Health News:BlueSky Synergy, a Division of Amistaff Healthcare Technology, and People 2.0 Global Partner to Provide Complimentary Staffing Software to Participating Companies 2Health News:BlueSky Synergy, a Division of Amistaff Healthcare Technology, and People 2.0 Global Partner to Provide Complimentary Staffing Software to Participating Companies 3Health News:Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural Products Expo East Show in Boston 2Health News:Jarrow Formulas, Inc. to Unveil Children's Natural Health Products at Upcoming Natural Products Expo East Show in Boston 3Health News:Dr. Brian Cahill Joins Research Triangle Dental 2Health News:Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Program's Graduation Ceremony on September 16th 2Health News:One Dose of Swine Flu Vaccine Offers Protection: Studies 2Health News:One Dose of Swine Flu Vaccine Offers Protection: Studies 3
(Date:9/1/2015)... --NOWDiagnostics Inc., based in Springdale, Ark. , ... Canada , a move that brings the company ... have greater access to information concerning their health. ... blood-based rapid tests that allow health care providers to ... ailments and diseases. ZBx Corporation, a Toronto ...
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Alpha Imaging LLC , a leading distributor ... announced today that they have been awarded exclusive rights to ... in Michigan.   The new territory supplements Alpha Imaging,s existing Shimadzu sales ... Ohio , Indiana , ... , West Virginia , Delaware ...
Breaking Medicine Technology:NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Alpha Imaging Expands Shimadzu Territory 2
... Medical Systems (NYSE: VAR ) today announced that ... N.A. to repurchase $250 million of its common stock under ... revolving credit facility with Bank of America, N.A. to increase ... Under the accelerated repurchase agreement, Varian will pay $250 ...
... Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced ... trial evaluating the safety and pharmacokinetics of dabigatran ... valves.(1) The 12-week study will compare three doses ... 300mg bid) to warfarin in patients with both ...
Cached Medicine Technology:Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 2Varian Medical Systems Announces $250 Million Accelerated Stock Repurchase; Increases Its Revolving Credit Facility 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 2Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 3Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 4Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 5Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 6Boehringer Ingelheim to Launch RE-ALIGN™ Trial to Evaluate Dabigatran Etexilate in Patients with Mechanical Heart Valves 7
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: